Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types [Phase 1]
IDEAYA Biosciences is conducting a Phase 1 study of IDE034 in adults with multiple locally advanced or metastatic solid tumors; the trial is…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer [Phase 3]
Phase III study evaluating Dato-DXd with or without durvalumab vs investigator's choice of chemotherapy in combination with pembrolizumab fo…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Breast Cancer PSMA PET [EARLY_Phase 1]
Early Phase 1 clinical trial investigating PSMA PET imaging in triple-negative breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 studies of the radiopharmaceutical 177Lu-BetaBart. The trial is evaluating its use in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC
A clinical trial update describing deployment and clinical evaluation of an AI-powered digital oncology biomarker tool to guide treatment in…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
This clinical trial update notes a Phase 1 study of BAL0891 by SillaJen in patients with advanced solid tumors, including triple-negative br…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer [NA]
A clinical trial is evaluating whether sentinel lymph node biopsy can be omitted after neoadjuvant therapy in patients with triple-negative …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating peri-operative immune checkpoint inhibition with cryoablation in women with triple-negative breast cancer;…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating a BLIS subtype-specific treatment for first-line locally advanced or metastatic triple-negative breast cancer is cu…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer [NA]
Phase II single-arm study evaluating camrelizumab in combination with radiochemotherapy as neoadjuvant therapy for early-stage triple-negati…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 [Phase 1]
Phase 1/1b trial evaluating RNDO-564 as a single agent or in combination with pembrolizumab in bladder cancer and nectin-4–associated solid …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer. [Phase 2]
Phase II study evaluating HLX43 alone or in combination with immune checkpoint inhibitors for locally advanced, recurrent, or metastatic tri…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients
The clinical trial investigates the relationship between tumor-infiltrating lymphocytes and blood cell counts in patients with triple-negati…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial investigating LifEStyle lifestyle intervention to enhance efficacy of neoadjuvant therapy in patients with early-stag…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer. [Phase 2]
A Phase 2 neoadjuvant trial evaluating high-intensity focused ultrasound (HIFU) with or without PD-1 inhibitors, followed by Abraxane (nab-p…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer [NA]
This ClinicalTrials.gov entry describes an ongoing study evaluating brain MRI screening in patients with breast cancer, including HER2-posit…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment
This clinical trial aims to establish an ex vivo collection of triple-negative breast cancers to evaluate innovative therapies and identify …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer [NA]
This entry describes a clinical trial focused on developing patient-derived xenografts from surgical tumor samples in patients with triple-n…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Access to Genetic Testing in Underserved Patients With Cancer [NA]
This entry reports on a clinical trial investigating access to genetic testing for cancer patients in underserved populations, with recruitm…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs [Phase 1]
Phase 1 dose randomization study evaluating Bulumtatug Fuvedotin in triple-negative breast cancer patients previously treated with antibody-…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging [NA]
A clinical trial evaluating early detection of metastatic recurrence in Stage II/III triple-negative breast cancer using liquid biopsy and i…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors [Phase 2]
A Phase 2 clinical trial of disitamab vedotin in combination with other anticancer drugs for solid tumors is currently recruiting, including…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating AK112 plus nab-paclitaxel versus placebo plus nab-paclitaxel as first-line treatment for inoperable locall…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer [Phase 2]
Phase 2 clinical trial comparing Tobemstomig plus nab-paclitaxel versus pembrolizumab plus nab-paclitaxel in previously untreated PD-L1-posi…